Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...
Merck KGaA (MKGAY) confirms “advanced discussions” with Springworks Therapeutics (SWTX) regarding a potential acquisition. “Merck also confirms that no legally binding agreement has been ...
Kineta has found a new home for deals with Genentech and Merck & Co. Tidying up the portfolio ahead of its merger with TuHURA Biosciences, the biotech has agreed to sell the deals to an investment ...
Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its ...
Germany’s Merck KGaA is in advanced talks to acquire SpringWorks, Reuters first reported Monday, citing people close to the matter. After the report, Merck KGaA later confirmed (PDF) the ...
The company also has a new literary division led by Jaidree Braddix, who was most recently at Park & Fine Literary and Media. Watch on Deadline “Publishing has always been a major part of ARC ...
Klaus has also driven strategic partnerships, such as the joint development of Lynparza with Merck/MSD. Earlier in his pharmaceutical industry career, Klaus held senior oncology-focused positions at ...
Beijing: With a long-term commitment to the Chinese market, US-based global pharmaceutical company Merck Sharp & Dohme (MSD) plans to introduce over 50 innovative drugs, vaccines, and companion ...
Compared to chemotherapy alone, Keytruda and Lynparza extended the time to disease progression or death, which MSD – known as Merck & Co in the US and Canada – said was "statistically ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results